Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection
The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis (PrEP) guidelines in June 2012 for men who have sex with men (MSM) who are at risk of HIV infection. With the flurry of data that has been generated in PrEP clinical research since the first guidelin...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2016-11-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4562 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329879463493632 |
|---|---|
| author | L. Bekker K. Rebe F. Venter G. Maartens M. Moorhouse F. Conradie C. Wallis V. Black B. Harley R. Eakles |
| author_facet | L. Bekker K. Rebe F. Venter G. Maartens M. Moorhouse F. Conradie C. Wallis V. Black B. Harley R. Eakles |
| author_sort | L. Bekker |
| collection | DOAJ |
| description | The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis (PrEP) guidelines in June 2012 for men who have sex with men (MSM) who are at risk of HIV infection. With the flurry of data that has been generated in PrEP clinical research since the first guideline, it became evident that there was a need to revise and expand the PrEP guidelines with new evidence of safety and efficacy of PrEP in several populations, including MSM, transgender persons, heterosexual men and women, HIV-serodiscordant couples and people who inject drugs. This need is particularly relevant following the World Health Organization (WHO) Consolidated Treatment Guidelines released in September 2015. These guidelines advise that PrEP is a highly effective, safe, biomedical option for HIV prevention that can be incorporated with other combination prevention strategies in Southern Africa, given the high prevalence of HIV in the region. PrEP should be tailored to populations at highest risk of HIV acquisition, whilst further data from studies in the region accrue to guide optimal deployment to realise the greatest impact regionally. PrEP may be used intermittently during periods of perceived HIV acquisition risk, rather than continually and lifelong, as is the case with antiretroviral treatment. Recognition and accurate measurement of potential risk in individuals and populations also warrants discussion, but are not extensively covered in these guidelines. |
| format | Article |
| id | doaj-art-b6e06dc23d0741a893a05e60878352e7 |
| institution | Kabale University |
| issn | 2078-6190 2078-6204 |
| language | English |
| publishDate | 2016-11-01 |
| publisher | AOSIS |
| record_format | Article |
| series | South African Family Practice |
| spelling | doaj-art-b6e06dc23d0741a893a05e60878352e72025-08-20T03:47:09ZengAOSISSouth African Family Practice2078-61902078-62042016-11-0158561710.4102/safp.v58i5.45623663Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infectionL. Bekker0K. Rebe1F. Venter2G. Maartens3M. Moorhouse4F. Conradie5C. Wallis6V. Black7B. Harley8R. Eakles9The Desmond Tutu HIV Centre, University of Cape TownAnova Health Institute, JohannesburgWits Reproductive Health and HIV Institute, JohannesburgDepartment of Medicine, University of Cape TownWits Reproductive Health and HIV Institute, JohannesburgRight to Care and Clinical HIV Research Unit, University of the WitwatersrandBARC, Johannesburg, South Africa; and, Lancet Laboratories, JohannesburgWits Reproductive Health and HIV Institute, JohannesburgCity Health, City of Cape TownWits Reproductive Health and HIV Institute, JohannesburgThe Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis (PrEP) guidelines in June 2012 for men who have sex with men (MSM) who are at risk of HIV infection. With the flurry of data that has been generated in PrEP clinical research since the first guideline, it became evident that there was a need to revise and expand the PrEP guidelines with new evidence of safety and efficacy of PrEP in several populations, including MSM, transgender persons, heterosexual men and women, HIV-serodiscordant couples and people who inject drugs. This need is particularly relevant following the World Health Organization (WHO) Consolidated Treatment Guidelines released in September 2015. These guidelines advise that PrEP is a highly effective, safe, biomedical option for HIV prevention that can be incorporated with other combination prevention strategies in Southern Africa, given the high prevalence of HIV in the region. PrEP should be tailored to populations at highest risk of HIV acquisition, whilst further data from studies in the region accrue to guide optimal deployment to realise the greatest impact regionally. PrEP may be used intermittently during periods of perceived HIV acquisition risk, rather than continually and lifelong, as is the case with antiretroviral treatment. Recognition and accurate measurement of potential risk in individuals and populations also warrants discussion, but are not extensively covered in these guidelines.https://safpj.co.za/index.php/safpj/article/view/4562southern african guidelinessafe usepre-exposure prophylaxishiv-1 infection |
| spellingShingle | L. Bekker K. Rebe F. Venter G. Maartens M. Moorhouse F. Conradie C. Wallis V. Black B. Harley R. Eakles Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection South African Family Practice southern african guidelines safe use pre-exposure prophylaxis hiv-1 infection |
| title | Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection |
| title_full | Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection |
| title_fullStr | Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection |
| title_full_unstemmed | Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection |
| title_short | Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection |
| title_sort | southern african guidelines on the safe use of pre exposure prophylaxis in persons at risk of acquiring hiv 1 infection |
| topic | southern african guidelines safe use pre-exposure prophylaxis hiv-1 infection |
| url | https://safpj.co.za/index.php/safpj/article/view/4562 |
| work_keys_str_mv | AT lbekker southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT krebe southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT fventer southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT gmaartens southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT mmoorhouse southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT fconradie southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT cwallis southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT vblack southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT bharley southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection AT reakles southernafricanguidelinesonthesafeuseofpreexposureprophylaxisinpersonsatriskofacquiringhiv1infection |